Feasibility and Smokers' Reactions to DNA Feedback
1 other identifier
interventional
39
1 country
1
Brief Summary
The purpose of the study is to explore how feedback of cellular DNA (Deoxyribonucleic Acid) damage, as a marker of exposure to the genotoxic agents of tobacco smoke, promotes cessation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2016
CompletedFirst Posted
Study publicly available on registry
October 4, 2016
CompletedStudy Start
First participant enrolled
February 14, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 24, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 24, 2017
CompletedJanuary 5, 2018
January 1, 2018
5 months
September 26, 2016
January 4, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Degree of participant understanding of materials, to be measured by a survey
Study will measure the extent to which the biomarker information was understood, as measured by a survey
week 3
Percentage of subjects who show up to the sessions
Study will collect feasibility data on how many participants come to each visit.
Week 1
Extent to which participants believe the feedback to be accurate
The study will measure the extent to which DNA damage results would be considered accurate using a survey.
week 3
Degree of participant understanding of materials, to be measured by an interview
Study will measure the extent to which the biomarker information was understood, as measured by an interview.
Week 3
Percentage of subjects who show up to the sessions
Study will collect feasibility data on how many participants come to each visit.
Week 3
Extent to which participants believe the feedback to be trustworthy
The study will measure the extent to which DNA damage results would be considered trustworthy using a survey.
Week 3
Extent to which participants believe the feedback to be accurate
The study will measure the extent to which DNA damage results would be considered accurate using an interview.
Week 3
Extent to which participants believe the feedback to be trustworthy
The study will measure the extent to which DNA damage results would be considered trustworthy using an interview.
Week 3
Secondary Outcomes (7)
Effect size of the changes in coherence between the control and biomarker arm from baseline to three months post-intervention on
Baseline to 3 months
Effect size of the change in risk appraisals between the control and biomarker arm from baseline to three months post-intervention on
Baseline to 3 months
Effect size of participant motivation to quit smoking between the control and biomarker arm from baseline to three months post-intervention on
Baseline to 3 months
Effect size of plans to quit smoking between the control and biomarker arm from baseline to three months post-intervention on
Baseline to 3 months
Effect size of mean levels of smoking between the control and biomarker arm at three months post-intervention
3 months
- +2 more secondary outcomes
Study Arms (3)
Control
ACTIVE COMPARATORSubjects will review standard health information on the health consequences of smoking. Subjects will have blood drawn but it will not be tested for DNA damage.
Biomarker feedback
ACTIVE COMPARATORSubjects will review this standardized health information, plus receive information on DNA damage along with feedback of their DNA damage. Subjects will have blood drawn and the feedback will be presented at Visit 2.
Biomarker feedback plus
ACTIVE COMPARATORSubjects will review this standardized health information, information on DNA damage along with feedback of their DNA damage, and will also will see images of their own cells with and without DNA damage. Subjects will have blood drawn and the feedback and images will be presented at Visit 2.
Interventions
Subjects will review standard health information and information on DNA damage
Subjects will review standard health information and information on DNA damage, as well as review pictures of their cells' DNA damage
Eligibility Criteria
You may qualify if:
- ages 18+
- smoke \> 5 cig/day during the last week
- be open to biomarker feedback
- not actively trying to quit
You may not qualify if:
- smoker carbon monoxide level(CO \< 10 ppm)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- Duke Cancer Institutecollaborator
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27701, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Isaac Lipkus, PhD
Duke University School of Nursing
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 26, 2016
First Posted
October 4, 2016
Study Start
February 14, 2017
Primary Completion
July 24, 2017
Study Completion
July 24, 2017
Last Updated
January 5, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share